|
US Patent Allowance Awarded, 1997
US Patent Allowance Awarded to Developer of Homeopathic Growth
Factor
Summer 1997
New Technology Includes Cost-Effective AIDS Medicines
UPTOWN HEALTH & SPIRIT
A promising new class of medications has been developed combining the
use of recent advances of biotechnology with the 200-year old science of
homeopathy. Biomed Comm®, a Seattle-based company, was recently
awarded a Patent Notice of Allowance making it the first company to patent
homeopathic growth factors for use as an alternative medicine. "These
homeopathic growth factors represent a new class of medicines, combining
today's advanced biotechnologies, modern biology and basic homeopathic
principles formed two centuries ago," said Dr. Barbara Brewitt,
Biomed® Chief Scientific Officer. Growth factors are a class of
polypeptides (proteins) produced naturally in the body. Classified by standard
textbooks as hormones, they regulate cell growth, division and specialization.
These proteins enable cells to communicate with one another, and are defined as
Cell Signal Enhancers® (CSE®) by Brewitt. CSEs® enable the cell to make appropriate responses to its surrounding environment.
Growth factors then help cells respond better to disruptions, such as disease.
Homeopathy is a form of natural medicine that uses minute amounts of
medicines to stimulate the body's defense system and healing process. Developed
over 200 years ago, homeopathic therapies often are so highly diluted that the
substances cannot even be measured in the body, and therefore are completely
non-toxic. The medicines are working at the cellular level to only stimulate
the body to develop its own defense and healing mechanism.
In the 1700s, German physician Samuel Hahnemann developed the principle
of the "Law of Similars". Today, the law remains as a defining principle of
homeopathy. It means that if a substance causes side effects and syndromes at
pharmacological, large or toxic doses, this same substance can heal these same
symptoms and syndromes when given in small does that have been serially diluted
and agitated. Hahnemann's years of observing the pharmacological effects of
drugs initiated his development of the Law of Similars.
Conventional medicine utilizes the Law of Similars in such common
treatments as allergens for allergy patients, in such drugs as ritalin for
hyperactive children, and in vaccines. But, whereas conventional medicine uses
high doses of these treatments - often to the level of overkill and the
production of side effects - homeopathy uses highly diluted and safe
concentrations that are neither toxic nor produce side effects. "It is the
first time that homeopathic growth factors have been tested for clinical
efficacy using a rigorous scientific model, such as a double-blind
placebo-controlled study," said Brewitt. Brewitt's clinical study in 1995
involved 30 HIV-positive individuals using a combination of four homeopathic
growth factors. The 16 week long clinical trial enrolled selected long-term
HIV/AIDS patients who had never used anti-viral therapies.
The results of the clinical studies have been recognized by the
National Institutes of Health Office of Alternative Medicine with a technical
merit ñ number-one rating for alternative approaches to HIV/AIDS.
Results included a reduction in viral load in patients on the treatment.
Patients on treatment also gained an average of 10 pounds, compared to patients
on placebo who lost weight. CD4 and CD8 cells increased in patients on
treatment while patients on placebo experienced decreases. There were no
opportunistic infections experienced by patients taking the homeopathic growth
factors. Results included a reduction in viral load in patients on the
treatment. Patients on treatment also gained an average of 10 pounds, compared
to patients on placebo, who lost weight. CD4 and CD8 cells increased in
patients on treatment while patients on placebo experienced decreases. There
were no opportunistic infections experienced by patients taking the homeopathic
growth factors. Also noted was a decline in the rate of inflammation in the
body of patients on treatment versus a rise in patients on placebo. There were
no adverse side effects noted. The many positive results led to an extended
yearlong open study with 30 patients. Biomed Comm® has continued
to follow the patients involved in the initial study for over 20 months through
quarterly blood tests.
The patients have fallen into three groups: one group elected to
maintain the growth factor protocol, a second group shifted to an
antiviral/protease inhibitor protocol and the third group elected to use only
natural products or nutritional supplements without growth factors.
Biomed® reports the group that has continued to use
growth factors is doing well; there have been no deaths, no opportunistic
infections, no inflammation, and viral loads are low, with no significant
difference from those patients taking expensive combinations of antiviral
therapy. CD4 and CD8 cell counts are insignificantly different from patients on
antiviral therapy. Growth factor patients have also achieved a higher weight
gain and are more stable than patients on antiviral or natural therapy, and
there have been no reported adverse side effects. This is especially
significant when compared to the new data on diabetes-induced conditions by
protease inhibitor and anti-viral therapy. The second and third groups have not
faired as well.
Biomed Comm® is currently halfway through a double-blind
placebo replication study to reconfirm the results of the original four-month
clinical trial. "
The concept of homeopathic growth factors represents a major
breakthrough in reduction of health-care costs for healthy and chronically ill
individuals," Dr. Brewitt said. "For reasons that homeopathic medications are
highly diluted, cost reductions by 80 to 90 percent over conventional medicines
are hoped to offer effective preventive options."
The proposed cost of the new, over-the-counter therapy of the four
homeopathic growth factors is about $4 per day or $1,440 per year, which is a
fraction of the cost of therapies involving combinations of antibiotics,
anti-retroviral and protease inhibitor drugs.
Homeopathic growth factors may also offer uses ideal for preventative
medicine. According to Dr. Brewitt, a careful delivery of homeopathic growth
factors will result in longer, healthier lives because of the maintenance of
long-term healthy homeostasis. The slowing of cell growth represents the
gradual deterioration of tissues and membranes, which happens naturally as we
age. Older individuals cell growth has slowed, and often they are more
susceptible to disease. Healthy human cells self-regulate through growth,
division and specialization. Only when an imposing outside element enters the
equation do abnormal changes occur. Brewitt believes these abnormal changes can
be brought back into balance via growth factors.
The company anticipates multiple-product applications as consumers
become knowledgeable in the science of growth factors for the promotion of
optimal health and therapeutic treatment.
|
Natural Menopause Relief
90 Tablets - Natural Menopause Relief contains recombinant Insulin-like Growth
Factor 1 (IGF-1) in a subtle 6C potency. This ingredient is not taken from
human or animal extracts but rather synthetically produced from a perfect human
blueprint, sugars, phosphates, and proteins using Good Manufacturing Practices.
Natural Menopause Relief aids in the regulation of hormones, relieving symptoms
of PMS, menopause, and helps to control appetite and urges. Chew 5 days
a week three times a day, 10 minutes after a breakfast, lunch, and dinner.
Do not consume any food or liquid 10 minutes before and 10 minutes after taking
this product to maximize effectiveness. Increase your water intake during
your day.
These tablets contain lactose.
|
|
